| Product Code: ETC8328151 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Monaco Oncology Companion Diagnostic Market Overview |
3.1 Monaco Country Macro Economic Indicators |
3.2 Monaco Oncology Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Monaco Oncology Companion Diagnostic Market - Industry Life Cycle |
3.4 Monaco Oncology Companion Diagnostic Market - Porter's Five Forces |
3.5 Monaco Oncology Companion Diagnostic Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.6 Monaco Oncology Companion Diagnostic Market Revenues & Volume Share, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
3.7 Monaco Oncology Companion Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Monaco Oncology Companion Diagnostic Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Monaco Oncology Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Monaco |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in diagnostic tools for oncology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 High cost associated with developing and commercializing companion diagnostics |
4.3.3 Limited awareness and access to oncology companion diagnostics in Monaco |
5 Monaco Oncology Companion Diagnostic Market Trends |
6 Monaco Oncology Companion Diagnostic Market, By Types |
6.1 Monaco Oncology Companion Diagnostic Market, By Product & Service |
6.1.1 Overview and Analysis |
6.1.2 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Product & Service, 2021- 2031F |
6.1.3 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Product, 2021- 2031F |
6.1.4 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Service, 2021- 2031F |
6.2 Monaco Oncology Companion Diagnostic Market, By Technology(Revenue, USD Million, 2021-2031) |
6.2.1 Overview and Analysis |
6.2.2 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Polymerase chain reaction (PCR), 2021- 2031F |
6.2.3 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Next-generation sequencing (NGS), 2021- 2031F |
6.2.4 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.2.5 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), 2021- 2031F |
6.2.6 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 Monaco Oncology Companion Diagnostic Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.3 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Non-small cell lung cancer, 2021- 2031F |
6.3.4 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.5 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.3.6 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.4 Monaco Oncology Companion Diagnostic Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Pathology/Diagnostic laboratory, 2021- 2031F |
6.4.4 Monaco Oncology Companion Diagnostic Market Revenues & Volume, By Academic medical center, 2021- 2031F |
7 Monaco Oncology Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Monaco Oncology Companion Diagnostic Market Export to Major Countries |
7.2 Monaco Oncology Companion Diagnostic Market Imports from Major Countries |
8 Monaco Oncology Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of oncology companion diagnostics by healthcare providers in Monaco |
8.2 Number of partnerships and collaborations between diagnostic companies and oncology treatment centers in Monaco |
8.3 Percentage of oncology patients in Monaco receiving personalized treatment based on companion diagnostic results |
9 Monaco Oncology Companion Diagnostic Market - Opportunity Assessment |
9.1 Monaco Oncology Companion Diagnostic Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
9.2 Monaco Oncology Companion Diagnostic Market Opportunity Assessment, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
9.3 Monaco Oncology Companion Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Monaco Oncology Companion Diagnostic Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Monaco Oncology Companion Diagnostic Market - Competitive Landscape |
10.1 Monaco Oncology Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Monaco Oncology Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here